well, we are kind of in the same camp... I see Alfrezza as a benefit for diabetics, have a close friend looking into getting it for himself because in his own words, its a pain in the keister to have to carry and chill insulin and use a needle...
and kind of agree, that my expectations for MNKD are for the near term, reduced... I still have a target price of my own of $7.5 as a first step. Which of course, gives me a lot of reason to not overpay or just sit on the shares I do own (one of the reasons why I sell covered calls when the opportunity presents)
I can honestly say, that the vision of a triple digit share price that was 'seen as possible' back in the 2008 timeframe has been forgotten for the moment due to the heavy dilution thru the shares released to keep moving forward. Not even clear if it can see $20 now with all the shares outstanding unless sales really take off.. (this will clear up as we get some numbers to work with in terms of 'profits' unit sold)
So investing for the moment, looking to be a heavy buyer once it finally shows it has bottomed, especially if it goes lower, cause I expect that IF the scripts start to show acceptance is developing in a growing way, it could move some on the 'hope' of more...
Good luck...